Questions Questions & Accountability? – Any dispensaries selling products that they actually own/create themselves and are also capturing data on the individual they sell to is questionable? Is it fair that the dispensary may give a patient/customer the impression that they are just the distributor when in fact they are distributing their own product that they created? Is it a Conflict Of Interest?

Delta-11-Tetrahydrocannabinol (Delta-11-THC, Δ11-THC, Δ9(11)-THC, exo-Tetrahydrocannabinol) is a synthetic isomer of tetrahydrocannabinol, developed in the 1970s. It can be synthesised from Δ8-THC by several different routes,[1][2][3] though only the (6aR, 10aR) enantiomer is known. In animal studies it was found to be active in mice with around 1/4 the potency of Δ9-THC,[4] but did not substitute for THC in rhesus monkeys, probably because the dose tested was not high enough to produce cannabinoid-like effects.[5][6] It has been identified as a component of “vaping liquids” sold for use in humans.